GeoVax Labs, Inc. (GOVX)
0.206
-0.01
(-3.15%)
USD |
NASDAQ |
Oct 23, 16:00
0.2035
0.00 (0.00%)
After-Hours: 20:00
GeoVax Labs Net Income (Quarterly) : -4.427M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.427M |
| March 31, 2026 | -5.262M |
| December 31, 2025 | -4.418M |
| September 30, 2025 | -6.319M |
| June 30, 2025 | -5.370M |
| March 31, 2025 | -5.358M |
| December 31, 2024 | -8.263M |
| September 30, 2024 | -5.816M |
| June 30, 2024 | -5.064M |
| March 31, 2024 | -5.850M |
| December 31, 2023 | -7.592M |
| September 30, 2023 | -8.409M |
| June 30, 2023 | -5.928M |
| March 31, 2023 | -4.038M |
| December 31, 2022 | -5.384M |
| September 30, 2022 | -3.968M |
| June 30, 2022 | -2.242M |
| March 31, 2022 | -2.428M |
| December 31, 2021 | -13.74M |
| September 30, 2021 | -1.950M |
| June 30, 2021 | -1.314M |
| March 31, 2021 | -1.563M |
| December 31, 2020 | -1.336M |
| September 30, 2020 | -0.5706M |
| June 30, 2020 | -0.4552M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5957M |
| December 31, 2019 | -0.5906M |
| September 30, 2019 | -0.4244M |
| June 30, 2019 | -0.6541M |
| March 31, 2019 | -0.7015M |
| December 31, 2018 | -0.6343M |
| September 30, 2018 | -0.6669M |
| June 30, 2018 | -0.637M |
| March 31, 2018 | -0.6218M |
| December 31, 2017 | -0.5162M |
| September 30, 2017 | -0.5888M |
| June 30, 2017 | -0.5169M |
| March 31, 2017 | -0.5483M |
| December 31, 2016 | -0.9354M |
| September 30, 2016 | -0.4642M |
| June 30, 2016 | -0.5758M |
| March 31, 2016 | -1.296M |
| December 31, 2015 | -0.6927M |
| September 30, 2015 | -0.6199M |
| June 30, 2015 | -0.6762M |
| March 31, 2015 | -0.7005M |
| December 31, 2014 | -0.9236M |
| September 30, 2014 | -0.5145M |
| June 30, 2014 | -0.6795M |
| March 31, 2014 | -0.6159M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.427M |
| EPS Diluted (Quarterly) | -0.9696 |
| Enterprise Value | -1.302M |
| Earnings Yield | -6.76K% |
| Normalized Earnings Yield | -6760.97 |